Aileron Therapeutics, Inc. ("Aileron") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of ...
The following is a summary of “Alveolar stem cell exhaustion, fibrosis, and bronchiolar proliferation” related entities. A narrative review,” published in the September 2024 issue of Pulmonology by ...
A panel of experts, including Dr Rohit Aggarwal, Principal Investigator of the decentralized Myositis Interstitial Lung ...
Idiopathic pulmonary fibrosis (IPF) is when the lungs become scarred, and breathing becomes increasingly difficult. Damage to the ...
BackgroundIdiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by unexplained ...
Subsequently, the researchers investigated the specific mesenchymal cell-induced interactions with alveolar epithelial cells in lung fibrosis. Presence of leucine-rich repeat-containing G- protein ...
Subsequently, the researchers investigated the specific mesenchymal cell-induced interactions with alveolar epithelial cells in lung fibrosis. Presence of leucine-rich repeat-containing G- protein ...
A study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF) in mice by inhibiting mitochondrion ...
Avalyn Pharma has initiated a Phase 1b clinical trial to test AP02, a therapeutic candidate for pulmonary fibrosis (PF), in adult healthy volunteers. The placebo-controlled trial of inhaled nintedanib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback